quote:

inspirator schreef op 20 december 2016 16:41:

Eerste bod is dan 7,65 euro per aandeel MdxHealth

quote:

inspirator schreef op 20 december 2016 16:41:

Eerste bod is dan 7,65 euro per aandeel MdxHealth

quote:

inspirator schreef op 11 januari 2017 19:52:

Amerikaanse biotechaandelen omlaag na opmerkingen Trump

Exact Sciences reageert niet op Trump zijn uitspraken, gewoon in de plus: www.nasdaq.com/symbol/exas

Was Jan Groen maar de broer van Donald Trump.

Of mag hij niet spreken ivm overnamebespreking met Exact Sciences ?

quote:

inspirator schreef op 11 januari 2017 19:58:

[...]

Exact Sciences has healthy results

Finally, Exact Sciences gained 19%. The maker of the Cologuard colon-cancer screening test gave preliminary fourth-quarter results, predicting that it would report sales of between $34.9 million and $35.4 million. That would be up more than 140% from year-ago levels, and Exact Sciences said it performed about 82,000 Cologuard tests during the quarter, more than double what it did during the same period in 2015. Progress in getting new healthcare providers and insurance companies to embrace the test had Exact Sciences CEO Kevin Conroy proclaiming that, "Cologuard is becoming a standard of care for 80 million Americans who should be screened for colon cancer." Final results won't be available until February, but investors are convinced that Exact Sciences is on exactly the right path toward success.

Read more: www.fool.com/investing/2017/01/09/why...

quote:

inspirator schreef op 11 januari 2017 23:47:

Kevin Conroy
don't matter who is in the Whitehouse, cancer stays a killer
detectiontechnology is going to change the world !

video.foxbusiness.com/v/5275444224001...

Geweldig interview met CEO Exact Sciences over Cologuard.
Cologuard; dna technology MdxHealth inside.

quote:

inspirator schreef op 11 januari 2017 23:47:

Kevin Conroy
don't matter who is in the Whitehouse, cancer stays a killer
detectiontechnology is going to change the world !

video.foxbusiness.com/v/5275444224001...

Geweldig interview met CEO Exact Sciences over Cologuard.
Cologuard; dna technology MdxHealth inside.

quote:

inspirator schreef op 10 januari 2017 18:45:

Mr. Roelandt joins MDxHealth after having served as Chief Financial Officer and Managing Director at BHF Kleinwort Benson (previously known as RHJ International) since 2006. In addition to his responsibilities as a member of BHF Kleinwort Benson Group's executive management, he was also appointed Executive Director and Chief Financial Officer of Kleinwort Benson Bank in London from July 2015 until the acquisition of the BHF Kleinwort Benson Group by Oddo & Cie in 2016.

Jean-Marc Roelandt was ook kortstondig directeur (tot overname) bij voorgaande werkgever.

De vette vis MdxHealth gaat bijten.